All Title Author
Keywords Abstract

PLOS ONE  2009 

IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity

DOI: 10.1371/journal.pone.0004261

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Little is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to establish biomarkers associated with infection and/or disease severity. Methods and Findings Adult patients with laboratory-confirmed Chikungunya fever infection, who were referred to the Communicable Disease Centre/Tan Tock Seng Hospital during the period from January to February 2008, were included in this retrospective study. Plasma fractions were analyzed using a multiplex-microbead immunoassay. Among the patients, the most common clinical features were fever (100%), arthralgia (90%), rash (50%) and conjunctivitis (40%). Profiles of 30 cytokines, chemokines, and growth factors were able to discriminate the clinical forms of Chikungunya from healthy controls, with patients classified as non-severe and severe disease. Levels of 8 plasma cytokines and 4 growth factors were significantly elevated. Statistical analysis showed that an increase in IL-1β, IL-6 and a decrease in RANTES were associated with disease severity. Conclusions This is the first comprehensive report on the production of cytokines, chemokines, and growth factors during acute Chikungunya virus infection. Using these biomarkers, we were able to distinguish between mild disease and more severe forms of Chikungunya fever, thus enabling the identification of patients with poor prognosis and monitoring of the disease.

References

[1]  Enserink M (2007) Tropical disease follows mosquitoes to Europe. Science 317: 1485.
[2]  Bonn D (2006) How did Chikungunya reach the Indian Ocean? Lancet Infect Dis 6: 543.
[3]  Beltrane A, Angheben A, Bisoffi Z, Monteiro G, Marocco S, et al. (2007) Imported Chikungunya infection, Italy. Emerg Infect Dis 13: 1262–56.
[4]  Leelarasamee A, Chupaprawan C, Chenchittikul M, Udompanthurat S (2004) Etiologies of acute undifferentiated febrile illness in Thailand. J Med Assoc Thai 87: 464–72.
[5]  AbuBakar S, Sam IC, Wong PF, MatRahim N, Hooi PS, Roslan N (2007) Reemergence of endemic Chikungunya, Malaysia. Emerg Infect Dis 13: 147–9.
[6]  Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, et al. (2007) Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 44: 1401–7.
[7]  Lakshmi V, Neeraja M, Subbalaxmi MVS, Parida MM, Dash PK, et al. (2008) Clinical features and molecular diagnosis of chikungunya fever from South India. Clin Infect Dis 46: 1436–42.
[8]  Pialoux G, Gauzère BA, Jauréguiberry S, Storbel M (2007) Chikungunya, an epidemic arbovirosis. Lancet 7: 319–27.
[9]  Powers AM, Logue CH (2007) Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 88: 2363–77.
[10]  Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, et al. (2006) Genome microevulotuion of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 3: e263.
[11]  Parola P, de Lamballerie X, Jourdan J, Rovery C, Vaillant V, et al. (2006) Novel Chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 12: 1493–9.
[12]  Reiter P, Fontenille D, Paupy C (2006) Aedes albopictus as an epidemic vector of Chikungunya virus: another emerging problem? Lancet Infect Dis 6: 463–4.
[13]  Charrel RN, de Lamballerie X, Raoult D (2007) Chikungunya outbreaks-the globalization of vectorborne diseases. New Engl J Med 356: 769–771.
[14]  Dash PK, Parida MM, Santhosh SR, Verma SK, Tripathi NK, et al. (2007) East Central South African genotype as the causative agent in re-emergence of Chikungunya outbreak in India. Vector Borne Zoonotic Dis 7: 519–27.
[15]  Chevillon C, Briant L, Renaud F, Devaux C (2008) The Chikungunya threat: an ecological and evolutionary perspective. Trends Microbio 16: 80–8.
[16]  Toivanen A (2008) Alphavirus: an emerging cause of arthritis? Current Opin Rheumatol 20: 486–90.
[17]  Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, et al. (2008) Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease duing the 2005–2006 outbreak on Reunion. Epidemiol Infect 11: 1–8.
[18]  Taubitz W, Cramer JP, Kapaun A, Pfeffer M, Drosten C, et al. (2007) Chikungunya fever in travellers: clinical presentations and course. Clin Infect Dis 45: e1–4.
[19]  Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, et al. (2008) A mouse model for Chikungunya: young and age and inefficient type 1 interferon signaling are risk factors for severe disease. PLoS Pathog 4: e29.
[20]  Ziegler SA, Lu L, Travassos da Rosa APA, Xiao S, Tesh RB (2008) An animal model for studying the pathogenesis of Chikungunya virus infection. Am J Trop Med Hyg 79: 133–9.
[21]  Lee N, Wong CK, Lam WY, Cockram CS, Sung JJY, et al. (2006) Chikungunya fever, Hong Kong. Emerg Infect Dis 12: 1790–2.
[22]  Ministry of Health SingaporeChikungunya Fever Cases Detected At Clive Street. Available at: . Accessed 12 August 2008.
[23]  Ministry of Health SingaporeUpdate on Chikungunya Fever Cases (5). Available at: . Accessed 12 August 2008.
[24]  Bone RC, Balk RA, Cerra FB, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (6): 1644–55.
[25]  Levi M (2004) Platelets at a crossroad of pathogenic pathways in sepsis. J Thromb Haemost 2: 2094–5.
[26]  Brun-Buisson C, Doyon F, Carlet J, et al. (1995) French ICU Group for Severe Sepsis. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA 274: 968–974.
[27]  Vanderschueren S, De Weerdt A, Malbrain M, et al. (2000) Thrombocytopenia and prognosis in intensive care. Crit Care Med 28: 1871–1876.
[28]  AIRD WC (2003) The Hematologic System as a Marker of Organ Dysfunction in Sepsis. Mayo Clin Proc 78: 869–881.
[29]  ProMED-mailChikungunya (07): Singapore. ProMED-mail 2008; 16 Feb: 20080216.0622. Available at . Accessed 23 March 2008.
[30]  Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, et al. (2007) Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370: 1840–6.
[31]  Gerardin P, Barau G, Michault A, Bintner M, Randrianaivo H, et al. (2008) Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the island of La Reunion. PLoS Med 5: e60.
[32]  Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, et al. (2007) Characterization of reemerging Chikungunya virus. PLoS Pathog 3: e89.
[33]  Liu YJ (2005) IPC: Professional Type I Interferon-producing cells and plasmacytoid dendritic cell precursors. Ann Rev Immunol 23: 275–306.
[34]  Hansmann L, Groeger S, von Wulffen W, Bein G, Hackstein H (2008) Human monocytes represent a competitive source of interferon-alpha in peripheral blood. Clin Immunol 172: 252–64.
[35]  Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, et al. (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101: 746–54.
[36]  Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, et al. (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180: 1395–1403.
[37]  Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, et al. (1995) IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leucok Bio 57: 763–6.
[38]  Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, et al. (1985) Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135: 3172–7.
[39]  Churchman SM, Ponchel F (2008) Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford) 47: 753–9.
[40]  Asquith DL, McInnes IB (2007) Emerging cytokine targets in rheumatoid arthritis. Curr Opin Rheumatol 19: 246–51.
[41]  Dalbeth N, Callan MF (2002) A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum 46: 1763–72.
[42]  Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, et al. (1990) Cytokine production in the rheumatoid joint: implications for treatment. Ann Rheum Dis 49: Suppl 1480–6.
[43]  Rot A, von Andrian UH (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22: 891–928.
[44]  Oka Y, Orth DN (1983) Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J Clin Invest 72: 249–59.
[45]  Wong CK, Lam CWK, Wu AKL, IP WK, Lee NLS, et al. (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136: 95–103.
[46]  Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, et al. (2005) Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 171: 850–7.
[47]  Avila-Aguero ML, Avila-Aguero CR, Um SL, Soriano-Fallas A, Canas-Coto A, Yan SB (2004) Systemic host inflammatory and coagulation response in the dengue virus primo-infection. Cytokine 27: 173–9.
[48]  Lee YR, Su CY, Chow NH, Lai WW, Lei HY, et al. (2007) Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES. Virus Res 126: 216–25.
[49]  Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095–2147.
[50]  Ellis M, al-Ramadi B, Hedstr?m U, Frampton C, Alizadeh H, Kristensen J (2005) Significance of the CC chemokine RANTES in patients with haematological malignancy: results from a prospective observational study. Br J Haematol 128: 482–9.
[51]  John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ (2006) Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis 194: 837–45.
[52]  Pérez AB, García G, Sierra B, Alvarez M, Vazquez S, et al. (2004) IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73: 230–4.
[53]  Hasebe F, Parquet MC, Pandey BD, Mathenge EG, Morita K, et al. (2002) Combined detection and genotyping of Chikungunya virus by a specific reverse transcription-polymerase chain reaction. J Med Virol 67: 370–4.
[54]  Wang E, Paessler S, Aguilar PV, Carrara AS, Ni H, et al. (2006) Reverse transcription-PCR-enzyme-linked immunosorbent assay for rapid detection and differentiation of alphavirus infections. J Clin Microbiol 44: 4000–8.
[55]  Caraux G, Pinloche S (2005) Permutmatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 21: 1280–1.
[56]  McQuitty LL (1996) Similarity analysis by reciprocal pairs for discrete and continuous data. Educ Psychol Meas 26: 825–31.
[57]  Kendall DG (1982) Seriation. In: Kotz S, Johnson NL, editors. Encyclopedia of Stastistical Sciences. 8. New York: NY Wiley-Interscience. pp. 417–24.

Full-Text

comments powered by Disqus